Jane Street’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$280K Sell
2,700
-1,400
-34% -$149K ﹤0.01% 9371
2025
Q4
$423K Sell
4,100
-177,100
-98% -$17.2M ﹤0.01% 8075
2025
Q3
$16.4M Buy
181,200
+83,100
+85% +$7.28M ﹤0.01% 1853
2025
Q2
$8.63M Buy
98,100
+62,400
+175% +$5.41M ﹤0.01% 2321
2025
Q1
$3.25M Buy
+35,700
New +$3.22M ﹤0.01% 3597

Other funds holding PPH

Jane Street's PPH Position: Q1 2026 in Review

Jane Street opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2026: 811,299 shares worth $84.3M. The stake represents 0.01% of the portfolio and ranks #732 among its holdings. This is a return to the name: Jane Street previously reported a position in PPH as recently as Q2 2025.

Jane Street first reported a position in PPH in Q2 2015 and has held it in 24 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Jane Street held 811,299 shares of VanEck Pharmaceutical ETF worth $84.3M as of Q1 2026.
  • VanEck Pharmaceutical ETF was a new Jane Street position in Q1 2026.
  • VanEck Pharmaceutical ETF made up 0.01% of Jane Street's portfolio in Q1 2026, its #732 holding.
  • Jane Street first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and has held it in 24 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.